Intensity Therapeutics Inc Now Sees IPO Of Up To 3.25M Shares Of Common Stock; Sees IPO Price Of Common Stock Between $4-$5/Share; The Benchmark Company, Freedom Capital Markets Are Now Joint Book Running Managers To IPO
Portfolio Pulse from Happy Mohamed
Intensity Therapeutics Inc plans to raise up to $16.25 million in its IPO, offering up to 3.25 million shares of common stock priced between $4-$5 per share. The Benchmark Company and Freedom Capital Markets are joint book running managers for the IPO.
May 18, 2023 | 6:56 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Intensity Therapeutics is planning an IPO of up to 3.25 million shares priced between $4-$5 per share, potentially raising up to $16.25 million.
The news of Intensity Therapeutics' IPO is directly related to the company's stock price and could generate interest from investors. The IPO pricing and the involvement of The Benchmark Company and Freedom Capital Markets as joint book running managers could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100